Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：55
作者：
Cardoso, F. [1 ]
Castiglione, M. [2 ]
机构：
[1] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium
[2] Univ Geneva, Inst Social & Prevent Med, Geneva, Switzerland
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
PACLITAXEL; DOCETAXEL; TRIAL;
D O I：
10.1093/annonc/mdp115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：15 / 18
页数：4
相关论文
共 11 条
[1]   Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment [J].
Albain, Kathy S. ;
Nag, Shona M. ;
Calderillo-Ruiz, German ;
Jordaan, Johann P. ;
Llombart, Antonio C. ;
Pluzanska, Anna ;
Rolski, Janusz ;
Melemed, Allen S. ;
Reyes-Vidal, Jose M. ;
Sekhon, Jagdev S. ;
Simms, Lorinda ;
O'Shaughnessy, Joyce .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) :3950-3957
[2]  
[Anonymous], NCCN CLIN PRACT GUID
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer [J].
Burstein, HJ ;
Kuter, I ;
Campos, SM ;
Gelman, RS ;
Tribou, L ;
Parker, LM ;
Manola, J ;
Younger, J ;
Matulonis, U ;
Bunnell, CA ;
Partridge, AH ;
Richardson, PG ;
Clarke, K ;
Shulman, LN ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2722-2730
[5]   Metastatic breast cancer - Recommendations proposal from the European School of Oncology (ESO)-MBC Task Force [J].
Cardoso, F. ;
Winer, E. P. ;
Fallowfield, L. ;
Namer, M. ;
Pagani, O. ;
Rodenhuis, S. ;
Senkus-Konefka, E. ;
Wardley, A. ;
Costa, A. .
BREAST, 2007, 16 (01) :9-10
[6]   Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer [J].
Chan, S ;
Friedrichs, K ;
Noel, D ;
Pintér, T ;
Van Belle, S ;
Vorobiof, D ;
Duarte, R ;
Gil, MG ;
Bodrogi, I ;
Murray, E ;
Yelle, L ;
von Minckwitz, G ;
Korec, S ;
Simmonds, P ;
Buzzi, F ;
Mancha, RG ;
Richardson, G ;
Walpole, E ;
Ronzoni, M ;
Murawsky, M ;
Alakl, M ;
Riva, A ;
Crown, J .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2341-2354
[7]   Achievements in systemic therapies in the pregenomic era in metastatic breast cancer [J].
Colozza, Mariantonietta ;
de Azambuja, Evandro ;
Personeni, Nicola ;
Lebrun, Fabienne ;
Piccart, Martine J. ;
Cardoso, Fatima .
ONCOLOGIST, 2007, 12 (03) :253-270
[8]   Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer [J].
Gennari, Alessandra ;
Amadori, Dino ;
De Lena, Mario ;
Nanni, Oriana ;
Bruzzi, Paolo ;
Lorusso, Vito ;
Manzione, Luigi ;
Conte, Pier Franco .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3912-3918
[9]   Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Kataja, V. ;
Castiglione, M. .
ANNALS OF ONCOLOGY, 2008, 19 :11-13
[10]   Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer [J].
Miller, Kathy ;
Wang, Molin ;
Gralow, Julie ;
Dickler, Maura ;
Cobleigh, Melody ;
Perez, Edith A. ;
Shenkier, Tamara ;
Cella, David ;
Davidson, Nancy E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26) :2666-2676
12